Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesSmall-cell prostate carcinoma: A retrospective analysis of five newly reported cases
Indian Journal of Urology, 06/26/09
Brownback KR et al. - The PSA levels varied greatly, with two patients possessing markedly elevated levels and the remaining patients with normal levels. Approximately 3/5 patients developed liver metastases, 2/5 patients had bone metastases, and 1/5 patients developed carcinomatous meningitis. Of the four patients who expired, the median survival time after diagnosis of SCC was 3.6 months (0.5-12 months).
Related Articles
Epac inhibits migration and proliferation of human prostate carcinoma cells
British Journal of Cancer, 11/20/09
Relevance Score: 68%
Extrapulmonary small cell carcinoma in breast and prostate
Clinical and Translational Oncology, 11/30/09
Relevance Score: 67%
Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip
Radiology Case Reports, 11/23/09
Relevance Score: 67%
Testosterone therapy and prostate carcinoma
Current Urology Reports, 11/17/09
Relevance Score: 66%
A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate
International Urology and Nephrology, 11/04/09
Relevance Score: 66%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/11/09
[F18]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study
European Journal of Cancer, 12/11/09
HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
The Prostate, 12/11/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
Cancer, 12/11/09
Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia
Current Opinion in Urology, 12/11/09
Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia
Current Opinion in Urology, 12/11/09
Article Search
Sponsor